Orgenesis Stock Technical Analysis
| ORGS Stock | USD 0.52 0.06 10.34% |
As of the 8th of February, Orgenesis holds the Risk Adjusted Performance of 0.2339, coefficient of variation of 359.77, and Semi Deviation of 28.88. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orgenesis, as well as the relationship between them. Please check Orgenesis downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Orgenesis is priced some-what accurately, providing market reflects its current price of 0.52 per share. As Orgenesis is a penny stock we also suggest to check out its total risk alpha numbers.
Orgenesis Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Orgenesis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OrgenesisOrgenesis |
Orgenesis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Orgenesis' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Orgenesis.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Orgenesis on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Orgenesis or generate 0.0% return on investment in Orgenesis over 90 days. Orgenesis is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide More
Orgenesis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Orgenesis' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Orgenesis upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 49.33 | |||
| Information Ratio | 0.2772 | |||
| Maximum Drawdown | 512.08 | |||
| Value At Risk | (75.71) | |||
| Potential Upside | 341.18 |
Orgenesis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orgenesis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Orgenesis' standard deviation. In reality, there are many statistical measures that can use Orgenesis historical prices to predict the future Orgenesis' volatility.| Risk Adjusted Performance | 0.2339 | |||
| Jensen Alpha | 33.88 | |||
| Total Risk Alpha | 21.06 | |||
| Sortino Ratio | 0.6611 | |||
| Treynor Ratio | (2.19) |
Orgenesis February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2339 | |||
| Market Risk Adjusted Performance | (2.18) | |||
| Mean Deviation | 76.39 | |||
| Semi Deviation | 28.88 | |||
| Downside Deviation | 49.33 | |||
| Coefficient Of Variation | 359.77 | |||
| Standard Deviation | 117.64 | |||
| Variance | 13838.65 | |||
| Information Ratio | 0.2772 | |||
| Jensen Alpha | 33.88 | |||
| Total Risk Alpha | 21.06 | |||
| Sortino Ratio | 0.6611 | |||
| Treynor Ratio | (2.19) | |||
| Maximum Drawdown | 512.08 | |||
| Value At Risk | (75.71) | |||
| Potential Upside | 341.18 | |||
| Downside Variance | 2433.06 | |||
| Semi Variance | 834.12 | |||
| Expected Short fall | (195.01) | |||
| Skewness | 2.21 | |||
| Kurtosis | 3.98 |
Orgenesis Backtested Returns
Orgenesis is out of control given 3 months investment horizon. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of 0.27, which implies the firm had a 0.27 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 29.06% are justified by taking the suggested risk. Use Orgenesis Risk Adjusted Performance of 0.2339, semi deviation of 28.88, and Coefficient Of Variation of 359.77 to evaluate company specific risk that cannot be diversified away. Orgenesis holds a performance score of 21 on a scale of zero to a hundred. The company holds a Beta of -14.92, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Orgenesis are expected to decrease by larger amounts. On the other hand, during market turmoil, Orgenesis is expected to outperform it. Use Orgenesis sortino ratio and the relationship between the downside variance and market facilitation index , to analyze future returns on Orgenesis.
Auto-correlation | -0.4 |
Poor reverse predictability
Orgenesis has poor reverse predictability. Overlapping area represents the amount of predictability between Orgenesis time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Orgenesis price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Orgenesis price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Orgenesis technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Orgenesis Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Orgenesis volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Orgenesis Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Orgenesis on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Orgenesis based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Orgenesis price pattern first instead of the macroeconomic environment surrounding Orgenesis. By analyzing Orgenesis's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Orgenesis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Orgenesis specific price patterns or momentum indicators. Please read more on our technical analysis page.
Orgenesis February 8, 2026 Technical Indicators
Most technical analysis of Orgenesis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Orgenesis from various momentum indicators to cycle indicators. When you analyze Orgenesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2339 | |||
| Market Risk Adjusted Performance | (2.18) | |||
| Mean Deviation | 76.39 | |||
| Semi Deviation | 28.88 | |||
| Downside Deviation | 49.33 | |||
| Coefficient Of Variation | 359.77 | |||
| Standard Deviation | 117.64 | |||
| Variance | 13838.65 | |||
| Information Ratio | 0.2772 | |||
| Jensen Alpha | 33.88 | |||
| Total Risk Alpha | 21.06 | |||
| Sortino Ratio | 0.6611 | |||
| Treynor Ratio | (2.19) | |||
| Maximum Drawdown | 512.08 | |||
| Value At Risk | (75.71) | |||
| Potential Upside | 341.18 | |||
| Downside Variance | 2433.06 | |||
| Semi Variance | 834.12 | |||
| Expected Short fall | (195.01) | |||
| Skewness | 2.21 | |||
| Kurtosis | 3.98 |
Orgenesis February 8, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Orgenesis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.58 | ||
| Daily Balance Of Power | (0.17) | ||
| Rate Of Daily Change | 0.90 | ||
| Day Median Price | 0.43 | ||
| Day Typical Price | 0.46 | ||
| Price Action Indicator | 0.07 | ||
| Market Facilitation Index | 0.35 |
Additional Tools for Orgenesis Pink Sheet Analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.